{
  "DOI": "10.1038/ejhg.2014.161",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2014.161",
  "alternative-id": [
    "BFejhg2014161"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "28 February 2014"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "26 June 2014"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "9 July 2014"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "20 August 2014"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "van den Broek",
      "given": "Alexandra J",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "de Ruiter",
      "given": "Karen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van 't Veer",
      "given": "Laura J",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tollenaar",
      "given": "Rob A E M",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Leeuwen",
      "given": "Flora E",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Verhoef",
      "given": "Senno",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Schmidt",
      "given": "Marjanka K",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2014,
        8,
        20
      ]
    ],
    "date-time": "2014-08-20T10:24:06Z",
    "timestamp": 1408530246000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:11:41Z",
    "timestamp": 1684429901000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        21
      ]
    ],
    "date-time": "2023-10-21T05:39:18Z",
    "timestamp": 1697866758735
  },
  "is-referenced-by-count": 12,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2014,
        8,
        20
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2015,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by-nc-sa/3.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2014,
            8,
            20
          ]
        ],
        "date-time": "2014-08-20T00:00:00Z",
        "timestamp": 1408492800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2014161.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2014161",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2014161.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "588-595",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2014,
        8,
        20
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2014,
        8,
        20
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2015,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "1117",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2014161_CR1",
      "unstructured": "Antoniou A, Pharoah PD, Narod S et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117–1130.",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/djt095",
      "author": "N Mavaddat",
      "doi-asserted-by": "publisher",
      "first-page": "812",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg2014161_CR2",
      "unstructured": "Mavaddat N, Peock S, Frost D et al: Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE 4. J Natl Cancer Inst 2013; 105: 812–822.",
      "volume": "105",
      "year": "2013"
    },
    {
      "DOI": "10.1136/jmedgenet-2013-101974",
      "author": "RM Brohet",
      "doi-asserted-by": "publisher",
      "first-page": "98",
      "journal-title": "J Med Genet",
      "key": "BFejhg2014161_CR3",
      "unstructured": "Brohet RM, Velthuizen ME, Hogervorst FB et al: Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations 1. J Med Genet 2014; 51: 98–107.",
      "volume": "51",
      "year": "2014"
    },
    {
      "DOI": "10.1126/science.1088759",
      "author": "MC King",
      "doi-asserted-by": "publisher",
      "first-page": "643",
      "journal-title": "Science",
      "key": "BFejhg2014161_CR4",
      "unstructured": "King MC, Marks JH, Mandell JB : Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302: 643–646.",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2006.09.1066",
      "author": "S Chen",
      "doi-asserted-by": "publisher",
      "first-page": "1329",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg2014161_CR5",
      "unstructured": "Chen S, Parmigiani G : Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007; 25: 1329–1333.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ejca.2006.07.019",
      "author": "FP Liebens",
      "doi-asserted-by": "publisher",
      "first-page": "238",
      "journal-title": "Eur J Cancer",
      "key": "BFejhg2014161_CR6",
      "unstructured": "Liebens FP, Carly B, Pastijn A, Rozenberg S : Management of BRCA1/2 associated breast cancer: a systematic qualitative review of the state of knowledge in 2006. Eur J Cancer 2007; 43: 238–257.",
      "volume": "43",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ijc.22817",
      "author": "MJ Bermejo-Perez",
      "doi-asserted-by": "publisher",
      "first-page": "225",
      "journal-title": "Int J Cancer",
      "key": "BFejhg2014161_CR7",
      "unstructured": "Bermejo-Perez MJ, Marquez-Calderon S, Llanos-Mendez A : Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review. Int J Cancer 2007; 121: 225–231.",
      "volume": "121",
      "year": "2007"
    },
    {
      "author": "SM Domchek",
      "first-page": "1",
      "journal-title": "LDI Issue Brief",
      "key": "BFejhg2014161_CR8",
      "unstructured": "Domchek SM, Rebbeck TR : Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations. LDI Issue Brief 2010; 16: 1–4.",
      "volume": "16",
      "year": "2010"
    },
    {
      "DOI": "10.1093/jnci/djn442",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "80",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg2014161_CR9",
      "unstructured": "Rebbeck TR, Kauff ND, Domchek SM : Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009; 101: 80–87.",
      "volume": "101",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nrclinonc.2010.166",
      "author": "SA Narod",
      "doi-asserted-by": "publisher",
      "first-page": "702",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "BFejhg2014161_CR10",
      "unstructured": "Narod SA : BRCA mutations in the management of breast cancer: the state of the art. Nat Rev Clin Oncol 2010; 7: 702–707.",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.2174/138945011798829438",
      "author": "SK Sandhu",
      "doi-asserted-by": "publisher",
      "first-page": "2034",
      "journal-title": "Curr Drug Targets",
      "key": "BFejhg2014161_CR11",
      "unstructured": "Sandhu SK, Yap TA, de Bono JS : The emerging role of poly(ADP-ribose) polymerase inhibitors in cancer treatment. Curr Drug Targets 2011; 12: 2034–2044.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ejca.2009.10.021",
      "author": "SK Sandhu",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Eur J Cancer",
      "key": "BFejhg2014161_CR12",
      "unstructured": "Sandhu SK, Yap TA, de Bono JS : Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective. Eur J Cancer 2010; 46: 9–20.",
      "volume": "46",
      "year": "2010"
    },
    {
      "DOI": "10.1146/annurev.genet.32.1.95",
      "author": "N Rahman",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "journal-title": "Annu Rev Genet",
      "key": "BFejhg2014161_CR13",
      "unstructured": "Rahman N, Stratton MR : The genetics of breast cancer susceptibility. Annu Rev Genet 1998; 32: 95–121.",
      "volume": "32",
      "year": "1998"
    },
    {
      "DOI": "10.1023/B:JOMG.0000048770.90334.3b",
      "author": "D Thompson",
      "doi-asserted-by": "publisher",
      "first-page": "221",
      "journal-title": "J Mammary Gland Biol Neoplasia",
      "key": "BFejhg2014161_CR14",
      "unstructured": "Thompson D, Easton D : The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 2004; 9: 221–236.",
      "volume": "9",
      "year": "2004"
    },
    {
      "DOI": "10.1093/annonc/mdq668",
      "author": "A Surbone",
      "doi-asserted-by": "publisher",
      "first-page": "i60",
      "issue": "Suppl 1",
      "journal-title": "Ann Oncol",
      "key": "BFejhg2014161_CR15",
      "unstructured": "Surbone A : Social and ethical implications of BRCA testing. Ann Oncol 2011; 22 (Suppl 1): i60–i66.",
      "volume": "22",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s12687-011-0042-4",
      "author": "D Gadzicki",
      "doi-asserted-by": "publisher",
      "first-page": "53",
      "journal-title": "J Community Genet",
      "key": "BFejhg2014161_CR16",
      "unstructured": "Gadzicki D, Evans DG, Harris H et al: Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genet 2011; 2: 53–69.",
      "volume": "2",
      "year": "2011"
    },
    {
      "key": "BFejhg2014161_CR17",
      "unstructured": "NABON. CBO (Dutch Institute for Healthcare Improvement) guideline for breast cancer; 2012 Available at: \n                    http://www.oncoline.nl/mammacarcinoom\n                    \n                   (last accessed on 26 June 2014)."
    },
    {
      "DOI": "10.1136/jmg.2009.067850",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "811",
      "journal-title": "J Med Genet",
      "key": "BFejhg2014161_CR18",
      "unstructured": "Evans DG, Lalloo F, Cramer A et al: Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 2009; 46: 811–817.",
      "volume": "46",
      "year": "2009"
    },
    {
      "DOI": "10.1186/1471-2407-9-86",
      "author": "SR Young",
      "doi-asserted-by": "publisher",
      "first-page": "86",
      "journal-title": "BMC Cancer",
      "key": "BFejhg2014161_CR19",
      "unstructured": "Young SR, Pilarski RT, Donenberg T et al: The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer 2009; 9: 86.",
      "volume": "9",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10549-014-2980-0",
      "author": "P Sharma",
      "doi-asserted-by": "publisher",
      "first-page": "707",
      "journal-title": "Breast Cancer Res Treat",
      "key": "BFejhg2014161_CR20",
      "unstructured": "Sharma P, Klemp JR, Kimler BF et al: Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing 3. Breast Cancer Res Treat 2014; 145: 707–714.",
      "volume": "145",
      "year": "2014"
    },
    {
      "DOI": "10.1038/sj.bjc.6603358",
      "author": "HH Kang",
      "doi-asserted-by": "publisher",
      "first-page": "914",
      "journal-title": "Br J Cancer",
      "key": "BFejhg2014161_CR21",
      "unstructured": "Kang HH, Williams R, Leary J, Ringland C, Kirk J, Ward R : Evaluation of models to predict BRCA germline mutations. Br J Cancer 2006; 95: 914–920.",
      "volume": "95",
      "year": "2006"
    },
    {
      "DOI": "10.1056/NEJM199705153362002",
      "author": "FJ Couch",
      "doi-asserted-by": "publisher",
      "first-page": "1409",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2014161_CR22",
      "unstructured": "Couch FJ, DeShano ML, Blackwood MA et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336: 1409–1415.",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1200/JCO.2002.20.6.1480",
      "author": "TS Frank",
      "doi-asserted-by": "publisher",
      "first-page": "1480",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg2014161_CR23",
      "unstructured": "Frank TS, Deffenbaugh AM, Reid JE et al: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002; 20: 1480–1490.",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1086/301670",
      "author": "G Parmigiani",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2014161_CR24",
      "unstructured": "Parmigiani G, Berry D, Aguilar O : Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998; 62: 145–158.",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1136/jmg.2003.017996",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "474",
      "journal-title": "J Med Genet",
      "key": "BFejhg2014161_CR25",
      "unstructured": "Evans DG, Eccles DM, Rahman N et al: A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 2004; 41: 474–480.",
      "volume": "41",
      "year": "2004"
    },
    {
      "key": "BFejhg2014161_CR26",
      "unstructured": "Schmidt MK et alBRCA1 and BRCA2 mutation spectrum in a hospital-based series of young breast cancer patients (unpublished)."
    },
    {
      "DOI": "10.1200/JCO.1999.17.5.1474",
      "author": "JM Harvey",
      "doi-asserted-by": "publisher",
      "first-page": "1474",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg2014161_CR27",
      "unstructured": "Harvey JM, Clark GM, Osborne CK, Allred DC : Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999; 17: 1474–1481.",
      "volume": "17",
      "year": "1999"
    },
    {
      "author": "DC Allred",
      "first-page": "155",
      "journal-title": "Mod Pathol",
      "key": "BFejhg2014161_CR28",
      "unstructured": "Allred DC, Harvey JM, Berardo M, Clark GM : Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 155–168.",
      "volume": "11",
      "year": "1998"
    },
    {
      "DOI": "10.1016/j.ejca.2009.03.008",
      "author": "MK Schmidt",
      "doi-asserted-by": "publisher",
      "first-page": "2376",
      "journal-title": "Eur J Cancer",
      "key": "BFejhg2014161_CR29",
      "unstructured": "Schmidt MK, Vermeulen E, Tollenaar RA, Van't Veer LJ, van Leeuwen FE : Regulatory aspects of genetic research with residual human tissue: effective and efficient data coding. Eur J Cancer 2009; 45: 2376–2382.",
      "volume": "45",
      "year": "2009"
    },
    {
      "DOI": "10.1093/jnci/djq088",
      "author": "E Amir",
      "doi-asserted-by": "publisher",
      "first-page": "680",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg2014161_CR30",
      "unstructured": "Amir E, Freedman OC, Seruga B, Evans DG : Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010; 102: 680–691.",
      "volume": "102",
      "year": "2010"
    },
    {
      "DOI": "10.1038/modpathol.3800453",
      "author": "E Honrado",
      "doi-asserted-by": "publisher",
      "first-page": "1305",
      "journal-title": "Mod Pathol",
      "key": "BFejhg2014161_CR31",
      "unstructured": "Honrado E, Benitez J, Palacios J : The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications. Mod Pathol 2005; 18: 1305–1320.",
      "volume": "18",
      "year": "2005"
    },
    {
      "key": "BFejhg2014161_CR32",
      "unstructured": "STOET-VGKN. Dutch CGC referral criteria (Stichting Opsporing Erfelijke Tumoren –Vereniging Klinische Genetica Nederland (STOET-VGKN) criteria), edition 1996 and 2001."
    },
    {
      "DOI": "10.1097/GIM.0b013e318159a318",
      "author": "KJ Schlich-Bakker",
      "doi-asserted-by": "publisher",
      "first-page": "766",
      "journal-title": "Genet Med",
      "key": "BFejhg2014161_CR33",
      "unstructured": "Schlich-Bakker KJ, ten Kroode HF, Warlam-Rodenhuis CC, van den Bout J, Ausems MG : Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer. Genet Med 2007; 9: 766–777.",
      "volume": "9",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1365-2354.2008.01065.x",
      "author": "E Van Riel",
      "doi-asserted-by": "publisher",
      "first-page": "369",
      "journal-title": "Eur J Cancer Care (Engl)",
      "key": "BFejhg2014161_CR34",
      "unstructured": "Van Riel E, Warlam-Rodenhuis CC, Verhoef S, Rutgers EJ, Ausems MG : BRCA testing of breast cancer patients: medical specialists’ referral patterns, knowledge and attitudes to genetic testing. Eur J Cancer Care (Engl) 2010; 19: 369–376.",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.2217/14796694.2.2.257",
      "author": "AC Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "257",
      "journal-title": "Fut Oncol",
      "key": "BFejhg2014161_CR35",
      "unstructured": "Antoniou AC, Easton DF : Risk prediction models for familial breast cancer. Fut Oncol 2006; 2: 257–274.",
      "volume": "2",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s10549-010-1137-z",
      "author": "C Bouchardy",
      "doi-asserted-by": "publisher",
      "first-page": "233",
      "journal-title": "Breast Cancer Res Treat",
      "key": "BFejhg2014161_CR36",
      "unstructured": "Bouchardy C, Benhamou S, Fioretta G et al: Risk of second breast cancer according to estrogen receptor status and family history. Breast Cancer Res Treat 2011; 127: 233–241.",
      "volume": "127",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ejca.2005.02.030",
      "author": "CC Warlam-Rodenhuis",
      "doi-asserted-by": "publisher",
      "first-page": "1409",
      "journal-title": "Eur J Cancer",
      "key": "BFejhg2014161_CR37",
      "unstructured": "Warlam-Rodenhuis CC, Koot VC, van der Luijt RB, Vasen HF, Ausems MG : A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients. Eur J Cancer 2005; 41: 1409–1415.",
      "volume": "41",
      "year": "2005"
    },
    {
      "DOI": "10.1200/JCO.2002.09.023",
      "author": "SR Lakhani",
      "doi-asserted-by": "publisher",
      "first-page": "2310",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg2014161_CR38",
      "unstructured": "Lakhani SR, Van De Vijver MJ, Jacquemier J et al: The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 2002; 20: 2310–2318.",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2010.28.0719",
      "author": "JS Kwon",
      "doi-asserted-by": "publisher",
      "first-page": "4214",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg2014161_CR39",
      "unstructured": "Kwon JS, Gutierrez-Barrera AM, Young D et al: Expanding the criteria for BRCA mutation testing in breast cancer survivors. J Clin Oncol 2010; 28: 4214–4220.",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1038/bjc.2012.31",
      "author": "L Robertson",
      "doi-asserted-by": "publisher",
      "first-page": "1234",
      "journal-title": "Br J Cancer",
      "key": "BFejhg2014161_CR40",
      "unstructured": "Robertson L, Hanson H, Seal S et al: BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer 2012; 106: 1234–1238.",
      "volume": "106",
      "year": "2012"
    },
    {
      "DOI": "10.1001/jama.297.23.2587",
      "author": "JN Weitzel",
      "doi-asserted-by": "publisher",
      "first-page": "2587",
      "journal-title": "JAMA",
      "key": "BFejhg2014161_CR41",
      "unstructured": "Weitzel JN, Lagos VI, Cullinane CA et al: Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 2007; 297: 2587–2595.",
      "volume": "297",
      "year": "2007"
    },
    {
      "key": "BFejhg2014161_CR42",
      "unstructured": "National Institute for Health and Care Excellence. CG164 Familial breast cancer: NICE guidance. Available at: \n                    http://guidance.nice.org.uk/CG164/NICEGuidance/pdf/English\n                    \n                  , 2013, (last accessed on 26 June 2014)."
    }
  ],
  "reference-count": 42,
  "references-count": 42,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2014161"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "23"
}